Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $475.00 at Evercore ISI

Intuitive Surgical (NASDAQ:ISRG) had its price target lifted by Evercore ISI from $410.00 to $475.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the stock. Morgan Stanley lifted their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an equal weight rating in a research note on Monday, July 15th. Redburn Atlantic raised Intuitive Surgical from a neutral rating to a buy rating and upped their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a buy rating in a research report on Friday, July 19th. BTIG Research lifted their price objective on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a buy rating in a research note on Wednesday, August 28th. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the stock a buy rating in a research note on Tuesday, July 16th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of Moderate Buy and an average price target of $449.70.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $481.95 on Tuesday. The stock has a market capitalization of $170.95 billion, a price-to-earnings ratio of 86.99, a PEG ratio of 5.39 and a beta of 1.39. Intuitive Surgical has a 1-year low of $254.85 and a 1-year high of $496.48. The company has a 50 day moving average price of $476.55 and a 200 day moving average price of $431.54.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company’s revenue was up 14.5% compared to the same quarter last year. During the same period last year, the company posted $1.18 EPS. On average, sell-side analysts expect that Intuitive Surgical will post 5.22 EPS for the current fiscal year.

Insider Activity

In related news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,120 shares of company stock worth $25,528,753. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several large investors have recently bought and sold shares of ISRG. Mirador Capital Partners LP lifted its holdings in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares in the last quarter. Goelzer Investment Management Inc. grew its position in shares of Intuitive Surgical by 0.6% in the 3rd quarter. Goelzer Investment Management Inc. now owns 6,321 shares of the medical equipment provider’s stock valued at $3,105,000 after purchasing an additional 39 shares during the period. HBW Advisory Services LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $235,000. MRA Advisory Group increased its stake in Intuitive Surgical by 28.7% during the 3rd quarter. MRA Advisory Group now owns 959 shares of the medical equipment provider’s stock worth $471,000 after purchasing an additional 214 shares in the last quarter. Finally, Czech National Bank raised its holdings in Intuitive Surgical by 6.9% during the 3rd quarter. Czech National Bank now owns 72,257 shares of the medical equipment provider’s stock worth $35,498,000 after buying an additional 4,665 shares during the period. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.